You are here
Clinical Trials: Eye Disease
Discuss
Each Clinical Trial will open in a new browser window or tab.
Conditions: Dry Macular Degeneration; Geographic Atrophy
Intervention: Biological: CPCB-RPE1
Sponsor: Regenerative Patch Technologies, LLC
Recruiting - verified January 2016
Intervention: Biological: CPCB-RPE1
Sponsor: Regenerative Patch Technologies, LLC
Recruiting - verified January 2016
Condition: Uveitis
Intervention: Other: intravitreous administration of regulator T-cells
Sponsor: Assistance Publique - Hôpitaux de Paris
Recruiting - verified June 2015
Intervention: Other: intravitreous administration of regulator T-cells
Sponsor: Assistance Publique - Hôpitaux de Paris
Recruiting - verified June 2015
Condition: Retinitis Pigmentosa
Intervention: Drug: hRPC
Sponsor: ReNeuron Limited
Recruiting - verified December 2015
Intervention: Drug: hRPC
Sponsor: ReNeuron Limited
Recruiting - verified December 2015
Conditions: Retinal Degeneration; Primary Open-angle Glaucoma
Interventions: Procedure: Intravitreal transplantation of mesenchymal stem cell; Biological: Culture and isolation of autologous bone-marrow mesenchymal stem cells
Sponsors: University of Sao Paulo; Conselho Nacional de Desenvolvimento Científico e Tecnológico
Recruiting - verified December 2014
Interventions: Procedure: Intravitreal transplantation of mesenchymal stem cell; Biological: Culture and isolation of autologous bone-marrow mesenchymal stem cells
Sponsors: University of Sao Paulo; Conselho Nacional de Desenvolvimento Científico e Tecnológico
Recruiting - verified December 2014
Condition: Retinitis Pigmentosa (RP)
Intervention: Biological: human retinal progenitor cells
Sponsor: jCyte, Inc
Recruiting - verified March 2016
Intervention: Biological: human retinal progenitor cells
Sponsor: jCyte, Inc
Recruiting - verified March 2016
Conditions: Cervical Spinal Cord Injury; Spine Injury; Spinal Cord Trauma
Intervention: Biological: AST-OPC1
Sponsor: Asterias Biotherapeutics, Inc.
Recruiting - verified May 2016
Intervention: Biological: AST-OPC1
Sponsor: Asterias Biotherapeutics, Inc.
Recruiting - verified May 2016
Condition: Age-related Macular Degeneration
Intervention: Biological: OpRegen
Sponsor: Cell Cure Neurosciences Ltd.
Recruiting - verified February 2016
Intervention: Biological: OpRegen
Sponsor: Cell Cure Neurosciences Ltd.
Recruiting - verified February 2016
Condition: Retinitis Pigmentosa
Interventions: Biological: Intravitreal injection of Autologous bone marrow Stem Cell; Other: Subconjunctival injection of saline
Sponsors: Red de Terapia Celular; Spanish National Health System; Hospital Universitario Virgen de la Arrixaca; Fundacion para la Formacion e Investigacion Sanitarias de la Region de Murcia; Public Health Service, Murcia; Instituto Murciano de Investigación Biosanitaria Virgen de la Arrixaca
Recruiting - verified September 2015
Interventions: Biological: Intravitreal injection of Autologous bone marrow Stem Cell; Other: Subconjunctival injection of saline
Sponsors: Red de Terapia Celular; Spanish National Health System; Hospital Universitario Virgen de la Arrixaca; Fundacion para la Formacion e Investigacion Sanitarias de la Region de Murcia; Public Health Service, Murcia; Instituto Murciano de Investigación Biosanitaria Virgen de la Arrixaca
Recruiting - verified September 2015
Conditions: Corneal Disease; Pterygium; Myopia; Hyperopia
Interventions: Procedure: LSCs and amniotic membrane (Modified Technique); Procedure: Amniotic membrane only (Traditional Technique); Procedure: PRK, LSCs, and amniotic membrane (Modified Technique); Procedure: PRK only (Traditional Technique); Drug: Levofloxacin; Drug: Betamethasone; Drug: Limbal stem cells (LSCs)
Sponsor: Sun Yat-sen University
Recruiting - verified May 2014
Interventions: Procedure: LSCs and amniotic membrane (Modified Technique); Procedure: Amniotic membrane only (Traditional Technique); Procedure: PRK, LSCs, and amniotic membrane (Modified Technique); Procedure: PRK only (Traditional Technique); Drug: Levofloxacin; Drug: Betamethasone; Drug: Limbal stem cells (LSCs)
Sponsor: Sun Yat-sen University
Recruiting - verified May 2014
Condition: Myopic Macular Degeneration
Intervention: Biological: MA09-hRPE Cellular Therapy
Sponsors: University of California, Los Angeles; Ocata Therapeutics
Recruiting - verified February 2016
Intervention: Biological: MA09-hRPE Cellular Therapy
Sponsors: University of California, Los Angeles; Ocata Therapeutics
Recruiting - verified February 2016
